Log In
Print
BCIQ
Print
Print this Print this
 

Vpriv, velaglucerase alfa (GA-GCB)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionGlucocerebrosidase enzyme replacement therapy
Molecular Target Not applicable
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentMarketed
IndicationGaucher's disease
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today